Clone:
REA1050
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
FC, MICS, IF, IHC, MC
Alternative names:
SELPLG, CD162, CLA, PSGL-1, PSGL1

Extended validation for Slan (M-DC8) Antibody, anti-human, REAfinity™

Sensitivity

Performance comparison
Selected fluorochrome conjugated antibodies from Miltenyi Biotec were compared to commercially available hybridoma clones in flow cytometry analysis.
View details
Flow cytometric comparison of different clones for Slan (M-DC8). Human peripheral blood mononuclear cells (PBMCs) after erythrocyte lysis were stained with Slan (M-DC8) antibodies and with a suitable counterstaining. As a control, Slan (M-DC8) antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals and 4',6-diamidino-2-phenylindole (DAPI) fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.
View details
Flow cytometric comparison of different clones for Slan (M-DC8). Human peripheral blood mononuclear cells (PBMCs) after erythrocyte lysis were stained with Slan (M-DC8) antibodies and with a suitable counterstaining. As a control, Slan (M-DC8) antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals and 4',6-diamidino-2-phenylindole (DAPI) fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.
View details
Flow cytometric comparison of different clones for Slan (M-DC8). Human peripheral blood mononuclear cells (PBMCs) after erythrocyte lysis were stained with Slan (M-DC8) antibodies and with a suitable counterstaining. As a control, Slan (M-DC8) antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals and 4',6-diamidino-2-phenylindole (DAPI) fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.
Flow cytometric comparison of different clones for Slan (M-DC8). Human peripheral blood mononuclear cells (PBMCs) after erythrocyte lysis were stained with Slan (M-DC8) antibodies and with a suitable counterstaining. As a control, Slan (M-DC8) antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals and 4',6-diamidino-2-phenylindole (DAPI) fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.
Fixation data
To provide an indication on how an antibody performs after fixation of cells, in-house data on staining results before and after fixation with 3.7% formaldehyde using Miltenyi Biotec antibodies are provided. Different experimental settings may lead to different results.
No fixation
Post fixation
View details
Comparison of staining pattern on non-fixed and fixed cells using Slan (M-DC8) (REA1050). The performance of the antibody after fixation was tested by comparing the staining pattern on fresh (no fixation) versus fixed (post fixation) cells.
View details
Comparison of staining pattern on non-fixed and fixed cells using Slan (M-DC8) (REA1050). The performance of the antibody after fixation was tested by comparing the staining pattern on fresh (no fixation) versus fixed (post fixation) cells.
Comparison of staining pattern on non-fixed and fixed cells using Slan (M-DC8) (REA1050). The performance of the antibody after fixation was tested by comparing the staining pattern on fresh (no fixation) versus fixed (post fixation) cells.

Specifications for Slan (M-DC8) Antibody, anti-human, REAfinity™

Overview

Clone REA1050 recognizes the human 6-sulfo LacNAc (Slan) (M-DC8) antigen, which is a carbohydrate modification of P-selectin glycoprotein ligand-1 (PSGL-1). This antigen is characteristically expressed on a new subset of peripheral blood mononuclear cells (PBMCs) with features closely related to CD16
+
CD14
low
monocytes. Slan (M-DC8)
+
cells constitute 0.5–2% of all PBMCs with similar frequencies among mononuclear cells from cord blood.
Additional information: Clone REA1050 displays negligible binding to Fc receptors.

Alternative names

SELPLG, CD162, CLA, PSGL-1, PSGL1

Detailed product information

Technical specifications

CloneREA1050
Clonalitymonoclonal
Isotyperecombinant human IgG1
Isotype controlREA Control Antibody (S), human IgG1
Hosthuman cell line
Type of antibodyPrimary antibodies, Recombinant antibodies
Specieshuman
AntigenSlan (M-DC8)
Alternative names of antigenSELPLG, CD162, CLA, PSGL-1, PSGL1
Molecular mass of antigen [kDa]39
Distribution of antigenmonocytes
Entrez Gene ID6404
RRIDAB_2751439, AB_2751442, AB_2751440, AB_2801906, AB_2751441

Resources for Slan (M-DC8) Antibody, anti-human, REAfinity™

Certificates

Please follow this
link
to search for Certificates of Analysis (CoA) by lot number.

References for Slan (M-DC8) Antibody, anti-human, REAfinity™

Publications

  1. Schäkel, K. et al. (1998)
    A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and
    in vitro
    priming of cytotoxic T lymphocytes.
    Eur. J. Immunol. 28: 4084-4093
  2. de Baey, A. et al. (2001)
    Phenotype and function of human dendritic cells derived from M-DC8
    +
    monocytes.
    Eur. J. Immunol. 31: 1646-1655
  3. Schäkel, K. et al. (2002) 6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells. Immunity 17: 289-301

Related products for
Slan (M-DC8) Antibody, anti-human, REAfinity™

3 products available

Seems like you are coming from USA!
Do you want to visit our website in your country?